MedTrace Logo

Hemostatic Procedure After Biopsy of the Cervix

NCT02486471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2016-02-17

No results posted yet for this study

Summary

Cytological abnormalities of the Cervix uteri need to be clarified by colposcopy biopsy. To avoid bleeding after biopsy, monsel´s paste is a common used Agent. In a randomized clinical Trial the use of monsel´s paste after biopsy will be compared to no Intervention. The Primary outcome of the study is blood loss, secondary outcomes are pain, satisfaction of the patient and influence of Independent factors such as Age and Body mass index.

Conditions

  • Uterine Cervical Dysplasia

Interventions

PROCEDURE

Monsel´s Paste

surgical method to stop bleeding by using the hemostatic Agent monsel´s paste until no more bleeding is visible

OTHER

Wait and see

finishing examination without hemostatic intervention, awaiting spontaneous coagulation

Sponsors & Collaborators

  • Zydolab - Institute of Cytology and Immune Cytochemistry

    lead OTHER

Principal Investigators

  • Ziad Hilal, M. D. · Zydolab - Institute of Cytology and Immune Cytochemistry

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-01-31
Completion
2016-02-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02486471 on ClinicalTrials.gov